Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Use-Results Survey of ONOACT for Tachyarrhythmias Associated With Sepsis
jRCT2041240118Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pafuramidine in Atrial fibrillation (AFib), atrial flutter (AFL) and sepsis, sponsored by Ono Pharmaceutical. Primary endpoints: Safety items - adverse drug reactions and infections, Factors influencing safety and 1 more. Started Jan 2021; status: completed.
02
Drugs
pafuramidine
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)sepsis
Beyond the preview
Go deeper on jRCT2041240118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041240118.